KR19990021931A - 미세구형 전분의 항편두통 조성물 - Google Patents

미세구형 전분의 항편두통 조성물 Download PDF

Info

Publication number
KR19990021931A
KR19990021931A KR1019970708406A KR19970708406A KR19990021931A KR 19990021931 A KR19990021931 A KR 19990021931A KR 1019970708406 A KR1019970708406 A KR 1019970708406A KR 19970708406 A KR19970708406 A KR 19970708406A KR 19990021931 A KR19990021931 A KR 19990021931A
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
starch
acid
microspheres
migraine
Prior art date
Application number
KR1019970708406A
Other languages
English (en)
Korean (ko)
Inventor
리스베트 일럼
Original Assignee
디르크 반테
얀센 파마슈티카 엔.브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 디르크 반테, 얀센 파마슈티카 엔.브이. filed Critical 디르크 반테
Publication of KR19990021931A publication Critical patent/KR19990021931A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1019970708406A 1995-06-08 1996-05-31 미세구형 전분의 항편두통 조성물 KR19990021931A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95201504 1995-06-08
EP95201504.8 1995-06-08

Publications (1)

Publication Number Publication Date
KR19990021931A true KR19990021931A (ko) 1999-03-25

Family

ID=8220362

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970708406A KR19990021931A (ko) 1995-06-08 1996-05-31 미세구형 전분의 항편두통 조성물

Country Status (5)

Country Link
KR (1) KR19990021931A (xx)
AU (1) AU6003896A (xx)
IL (1) IL118606A0 (xx)
WO (1) WO1996041632A1 (xx)
ZA (1) ZA964879B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2771929B1 (fr) * 1997-12-09 2001-02-23 Biovector Therapeutics Utilisation dans une composition pharmaceutique pour l'administration par voie nasale de particules hydrophiles pour la delivrance d'agents actifs au systeme nerveux central
JP4865989B2 (ja) 2002-02-01 2012-02-01 ベンド・リサーチ・インコーポレーテッド 改良された噴霧乾燥装置を使用する均質な噴霧乾燥された固体の非晶質薬物分散物を製造する方法
CN103409250A (zh) * 2013-07-18 2013-11-27 吴江市利达上光制品有限公司 一种水果专用洗涤精的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9116610D0 (en) * 1991-08-01 1991-09-18 Danbiosyst Uk Preparation of microparticles
SI9300097B (en) * 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines

Also Published As

Publication number Publication date
WO1996041632A1 (en) 1996-12-27
IL118606A0 (en) 1996-10-16
AU6003896A (en) 1997-01-09
ZA964879B (en) 1997-12-08

Similar Documents

Publication Publication Date Title
US5514673A (en) Pharmaceutical composition containing lipophilic drugs
US20130224300A1 (en) Compositions and methods thereof for oral administration of drugs
KR910004572B1 (ko) 경구용 당뇨병 치료제 제형의 제조방법
US20160030399A1 (en) Method of reducing somnolence in patients treated with tizanidine
US20110262496A1 (en) Therapeutic formulation for reduced drug side effects
JP6295314B2 (ja) 治療薬を送達するための方法および組成物
US11400045B2 (en) Treatment with powdered intranasal epinephrine
WO2009015561A1 (fr) Utilisation de léonurine et compositions
KR19990021931A (ko) 미세구형 전분의 항편두통 조성물
RU2240784C1 (ru) Лекарственное средство на основе арбидола
ES2930376T3 (es) Formulación farmacéutica
EP2958550B1 (en) Oral formulation and suspension of an oncology drug
JP2003503443A (ja) Ｇｒｆ含有凍結乾燥薬剤組成物
CN108289840A (zh) 用于静脉内注射Danirixin的制剂
FI93307C (fi) Menetelmä oktreotidiä sisältävän farmaseuttisen koostumuksen valmistamiseksi
WO2008106738A1 (en) Compositions for the treatment of sexual dysfunction
RU2174391C1 (ru) Фармацевтическая композиция с антидепрессантной активностью
CA3199479A1 (en) Lipocalin mutein dry powder formulation for treatment of asthma
EP1660522A2 (en) Pharmaceutical composition with increased bioavailability suitable for the administration of oral retroviral protease inhibitors. process for preparing a concentrate pharmaceutical composition comprising a retroviral protease inhibitor

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid